GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cinclus Pharma Holding AB (OSTO:CINPHA) » Definitions » Shares Buyback Ratio %

Cinclus Pharma Holding AB (OSTO:CINPHA) Shares Buyback Ratio % : 0.00 (As of Apr. 17, 2025)


View and export this data going back to 2024. Start your Free Trial

What is Cinclus Pharma Holding AB Shares Buyback Ratio %?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. Cinclus Pharma Holding AB's current shares buyback ratio was 0.00%.

Cinclus Pharma Holding AB Shares Buyback Ratio % Historical Data

The historical data trend for Cinclus Pharma Holding AB's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cinclus Pharma Holding AB Shares Buyback Ratio % Chart

Cinclus Pharma Holding AB Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Shares Buyback Ratio %
- - -7.60 -

Cinclus Pharma Holding AB Quarterly Data
Dec21 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Shares Buyback Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only -7.60 - - - -

Cinclus Pharma Holding AB Shares Buyback Ratio % Calculation

Cinclus Pharma Holding AB's Shares Buyback Ratio for the fiscal year that ended in Dec. 2024 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Dec. 2023 ) - Shares Outstanding (EOP) (A: Dec. 2024 )) / Shares Outstanding (EOP) (A: Dec. 2023 )
=(46.538 - 46.538) / 46.538
=0.00%

Cinclus Pharma Holding AB's Shares Buyback Ratio for the quarter that ended in Dec. 2024 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Sep. 2024 ) - Shares Outstanding (EOP) (A: Dec. 2024 )) / Shares Outstanding (EOP) (A: Sep. 2024 )
=(46.538 - 46.538) / 46.538
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cinclus Pharma Holding AB Shares Buyback Ratio % Related Terms

Thank you for viewing the detailed overview of Cinclus Pharma Holding AB's Shares Buyback Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.

Cinclus Pharma Holding AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cinclus Pharma Holding AB (OSTO:CINPHA) » Definitions » Shares Buyback Ratio %
Comparable Companies
OSTO:DICOT OSTO:ORX OSTO:MOB OSTO:KLAR XSAT:ACUC OSTO:NANEXA OSTO:ERMA OSTO:VIVE OSTO:TOL OSTO:ENZY ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD XSWX:SDZ HKSE:03692 NSE:DIVISLAB XTAE:TEVA
Traded in Other Exchanges
N/A
Address
Kungsbron 1, Stockholm, SWE, SE-111 22
Website
https://www.cincluspharma.com
Cinclus Pharma Holding AB is a clinical stage pharmaceutical company developing a drug for the treatment of erosive gastroesophageal reflux diseases, and a dual therapy treatment with an antibiotic targeting Helicobacter pylori which is a bacteria that occurs in the gastric and duodenal mucosa. The Company's main target population is patients suffering from severe eGERD, where there is a lack of satisfactory treatment options.

Cinclus Pharma Holding AB Headlines

No Headlines